📰 Moderna Efficacy News
Moderna Efficacy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Moderna Efficacy. Real-time updates on events, politics, business and more.
February 12, 2022
The efficacy of third or booster doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US CDC has found.
October 12, 2021
Be approved. even though the moderna efficacy has held up i think youre still seeing a decrease in efficacy over time of people who were older. if i were to predict something, i think they might take a similar route to pfizer just to align the two mrna vaccines and not cause more confusion. but well have to wait and see. >> our guest tonight has been one of the public health physicians who has guided us through this pandemic so far. our thanks as always for taking our questions tonight. anothe...
May 25, 2021
Moderna said Tuesday its Covid-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the US. With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest to end the pandemic. But earlier this month, the US and Canada authorized another vaccine the shot made by Pfizer and BioNTech to be used starting at age 12. Moderna aims to be next in line, saying it will subm...
May 25, 2021
Myocarditis is an "inflammation of the heart muscle that decreases the ability of the heart to pump blood normally," according to Harvard Health. Medical experts say the condition is usually caused by viral infections but can also be the body’s reaction to a drug. "Weve not seen reports of that locally here," Arwady said. "We have asked doctors just to be on the lookout if we were to see it, but this is not like when the [Johnson & Johnson vaccine] was paused. This is sort of, you know, more ...
May 24, 2021
The majority of cases have largely been reported after the second dose, typically within four days after vaccination. The panel notes that "most cases appear to be mild, and follow-up of cases is ongoing," but it did not offer details on how many cases have so far been reported. "Within CDC safety monitoring systems, rates of myocarditis reports in the window following COVID-19 vaccination have not differed from expected baseline rates," the panel stated. "However, VaST members felt that info...